je.st
news
Analysts Weigh In On MannKind Following Q4 Results
2015-02-28 21:07:46| Biotech - Topix.net
MannKind Corporation announced its fourth-quarter fiscal 2014 earnings report on Wednesday, February 24th, with results generally in line with expectations. Highlights from the report include a loss of -$0.09 a share, up from a loss of -$0.16 the same quarter a year prior.
Tags: results
analysts
weigh
q4
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||